• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    UpHealth Completes Sale of Cloudbreak Health at $180 Million Full Cash Deal

    3/18/24 8:30:10 AM ET
    $UPH
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $UPH alert in real time by email

    DELRAY BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("we," "our," "UpHealth," or the "Company") (NYSE:UPHL) today announced that it completed its previously announced sale of Cloudbreak Health, LLC ("Cloudbreak"), best known for its Martti™ translation offering, to a newly formed entity controlled by GTCR LLC for $180 million in gross cash proceeds on March 15, 2024.

    The $180 million in gross proceeds will be used to pay all closing expenses including any potential liability for taxes on the sale and paying down the Company's debt, including all of the Company's $115 million 2026 Notes and a substantial portion of its $57.2 million 2025 Notes.

    "This transaction is one more critical milestone in the last three years of UpHealth, Inc.'s journey to focus the Company on its strategic core and most profitable businesses. This major restructuring includes so far, shutting down the non-profitable businesses that also presented challenging legal risks, as well as divesting and selling profitable businesses that did not have a good strategic fit to our mission. The sale announced today of Cloudbreak, and the sale of IGI in May 2023 in a $56 million cash deal, have together generated to the Company about $235 million of cash that has allowed us to significantly reduce the liabilities of the Company and enhance its business focus and the financial performance, all resulting in unlocking meaningful value to our stakeholders. Moving forward we will focus solely on the very important purposed behavioral health business as we enhance investments in the profitable TTC Healthcare operation." said Dr Avi Katz, Chairman of the Board of Directors.

    "The Cloudbreak sale transaction will significantly deleverage our balance sheet, stabilize our business and empower us to concentrate our resources on TTC Healthcare," said Martin Beck, Chief Executive Officer. "TTC is a profitable and cash-generating behavioral health business with an incredibly bright future and we look forward to working with our talented team to profitably scale and deliver high-quality care to more patients. We are proud to continue to increase our presence in the behavioral health sector which is one of the most critical healthcare verticals for all U.S. and global citizens, regardless of age, gender, sexual orientation, religion, nationality and ethnicity."

    TTC Healthcare currently provides its patients with a full continuum of evidence-based mental health and substance use disorder services in four facilities with 159 licensed beds in Florida. The business continues to show strong census growth, with an attractive payor mix, including the U.S. Department of Veterans Affairs.

    UpHealth will provide a detailed financial analysis of the financial impacts of the Cloudbreak sale on its balance sheet and income statement in our upcoming Annual Report on Form 10-K, expected to be filed before the end of the month.

    Additional Detail on the Proceeds from the Sale

    The proceeds of the Cloudbreak sale, after transaction-related fees and expenses, have been deposited into three escrow accounts: a Notes escrow ($139 million), a Tax escrow ($27 million) and a Working Capital escrow ($3 million). Funds in the Notes escrow will be released on approximately June 3, 2024, but no later than June 15, 2024, and will be used to satisfy in full, plus accrued interest, the Company's 2026 Notes and to repurchase approximately $20 million of the Company's 2025 Notes, plus accrued interest, leaving approximately $37 million of 2025 Notes outstanding, which will constitute the Company's entire long term debt. Funds in the Tax escrow will be used to satisfy the Company's 2024 tax liability and any funds not required for this purpose will be used to repurchase additional 2025 Notes. Funds in the Working Capital escrow will be used to satisfy any obligations of the Company resulting from a difference between Cloudbreak's targeted and actual working capital as of the closing of the transaction, and any funds not used for this purpose will also be used to repurchase additional 2025 Notes.

    About UpHealth, Inc.

    UpHealth, Inc. is a leading provider of a full continuum of behavioral health solutions through the utilization of evidence-based treatments and services. Operating through its TTC Healthcare, Inc. subsidiary, UpHealth targets mental health issues and substance use disorders with services provided by psychiatrists, physicians, neurologists, licensed therapists, and clinical social workers. The Company's levels of care include detox, residential, partial hospitalization programs, intensive outpatient programs, outpatient, and telehealth. UpHealth's clients include health plans, healthcare providers and community-based organizations. For more information, please visit https://uphealthinc.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, statements regarding the repurchases of the 2026 Notes and 2025 Notes and the availability of funds in the Tax escrow and Working Capital escrow that may be used for this purpose, in each case, including the amounts and timing thereof, the projected operation and financial performance of the Company and its various subsidiaries, including TTC Healthcare, its product offerings and developments and reception of its product by customers, and the Company's expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future revenue and the business plans of the Company's management team. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company considering their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the ability of the Company to utilize funds in the Notes escrow and Working Capital escrow for the repurchases of the 2026 Notes and 2025 Notes, the ability of the Company to service or otherwise pay its debt obligations following such repurchases, including to holders of the Company's notes that will remain outstanding, the mix of services utilized by the Company's customers and such customers' needs for these services, market acceptance of new service offerings, the ability of the Company to scale and expand what it does for existing customers as well as to add new customers, whether the Company will be able to regain and sustain compliance with the continued listing standards of the NYSE or comply with the initial listing standards of another national securities exchange, uncertainty with respect to how the International Court of Arbitration or the Indian courts shall decide various matters that are before them or that the board of directors of Glocal Healthcare Systems Private Limited ("Glocal") will act in compliance with its fiduciary duties to Glocal's shareholders, and that the Company will have sufficient capital to operate as anticipated. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as may be required under applicable securities laws.

    Contact:

    Jude Gorman/Dan Moore

    Collected Strategies

    [email protected]



    Get the next $UPH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UPH

    DatePrice TargetRatingAnalyst
    3/31/2022$6.00 → $1.00Buy → Hold
    Lake Street
    10/25/2021$6.00Buy
    Lake Street
    7/22/2021$12.00Outperform
    Oppenheimer
    7/13/2021$13.00Outperform
    Northland Capital
    More analyst ratings

    $UPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UpHealth downgraded by Lake Street with a new price target

      Lake Street downgraded UpHealth from Buy to Hold and set a new price target of $1.00 from $6.00 previously

      3/31/22 8:59:33 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Lake Street initiated coverage on UpHealth with a new price target

      Lake Street initiated coverage of UpHealth with a rating of Buy and set a new price target of $6.00

      10/25/21 9:33:22 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Oppenheimer initiated coverage on UpHealth with a new price target

      Oppenheimer initiated coverage of UpHealth with a rating of Outperform and set a new price target of $12.00

      7/22/21 7:07:38 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Beck Martin S A

      4 - UpHealth, Inc. (0001770141) (Issuer)

      2/15/24 4:29:53 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4 filed by Locke Nathan

      4 - UpHealth, Inc. (0001770141) (Issuer)

      2/2/24 6:24:51 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Greene James S was granted 100,000 shares (SEC Form 4)

      4 - UpHealth, Inc. (0001770141) (Issuer)

      2/2/24 6:23:53 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $UPH
    Leadership Updates

    Live Leadership Updates

    See more
    • UpHealth Announces CEO Transition and Organizational Changes

      Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replac

      7/15/24 4:15:00 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • The International Court of Arbitration awarded UpHealth Holdings more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare Systems

      DELRAY BEACH, Fla., March 20, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth") (OTC:UPHL), a global digital health company delivering a full continuum of behavioral health solutions through the utilization of evidence-based treatments and services, today provided an update on the arbitration brought by UpHealth Holdings, Inc., a wholly-owned direct subsidiary of UpHealth ("Holdings"), against Glocal Healthcare Systems ("Glocal") and several of Glocal's officers and shareholders (together with Glocal, the "Respondents"). On March 18, 2024, the International Court of Arbitration of the International Chamber of Commerce (the "ICA") transmitted the Final Award to the parties. In the Final

      3/20/24 5:00:04 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Completes Sale of Cloudbreak Health at $180 Million Full Cash Deal

      DELRAY BEACH, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("we," "our," "UpHealth," or the "Company") (NYSE:UPHL) today announced that it completed its previously announced sale of Cloudbreak Health, LLC ("Cloudbreak"), best known for its Martti™ translation offering, to a newly formed entity controlled by GTCR LLC for $180 million in gross cash proceeds on March 15, 2024. The $180 million in gross proceeds will be used to pay all closing expenses including any potential liability for taxes on the sale and paying down the Company's debt, including all of the Company's $115 million 2026 Notes and a substantial portion of its $57.2 million 2025 Notes. "This transaction is one m

      3/18/24 8:30:10 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces CEO Transition and Organizational Changes

      Jay Jennings Appointed Acting Chief Executive Officer of UpHealth; Replacing Martin Beck Announces the Promotion of Lisa Fluxman to President of TTC Healthcare Reaffirms Jeremy Livianu as Chief Legal Officer and Secretary of UpHealth DELRAY BEACH, Fla., July 15, 2024 /PRNewswire/ -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the July 11, 2024 appointment by the Board of Directors of the Company of Jay Jennings, currently the Company's Chief Financial Officer, to serve as the Company's Acting Chief Executive Officer, replac

      7/15/24 4:15:00 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces CEO Transition and Organizational Changes

      Martin Beck Appointed CEO, Replacing Samuel Meckey Announces the Elimination of 20 Corporate Roles DELRAY BEACH, Fla., Oct. 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth," the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the October 5, 2023 appointment by the Board of Directors of the Company of Martin Beck to serve as the Company's next Chief Executive Officer, replacing Samuel Meckey, effective October 6, 2023, and Mr. Beck being named as a member of the Board of Directors effective October 9, 2023. Mr. Beck has been UpHealth's Chie

      10/11/23 8:30:00 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces Results of First Annual Stockholder Meeting

      Proposed New Independent Board Members Elected Stockholders Approved Reverse Split of the Company's Shares Stockholders Approve New Independent Auditor DELRAY BEACH, Fla., Dec. 05, 2022 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) announces the results of its first annual stockholder meeting, held December 5, 2022, virtually. All resolutions submitted for stockholder approval were adopted, including the following: Election of three Class I directors to hold office until the 2025 annual meeting and until their respective successors are elected and qualified.Approval of reverse stock split.Ratification of the appointment of BPM LLP as independent registered public accountin

      12/5/22 4:11:00 PM ET
      $COLB
      $UMPQ
      $UPH
      Savings Institutions
      Finance
      Commercial Banks
      Retail: Computer Software & Peripheral Equipment

    $UPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by UpHealth Inc. (Amendment)

      SC 13D/A - UpHealth, Inc. (0001770141) (Subject)

      11/29/23 4:03:50 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13D/A filed by UpHealth Inc. (Amendment)

      SC 13D/A - UpHealth, Inc. (0001770141) (Subject)

      11/27/23 8:34:32 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13D filed by UpHealth Inc.

      SC 13D - UpHealth, Inc. (0001770141) (Subject)

      11/27/23 8:20:19 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    SEC Filings

    See more
    • SEC Form DEFA14A filed by UpHealth Inc.

      DEFA14A - UpHealth, Inc. (0001770141) (Filer)

      2/15/24 4:48:59 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

      8-K - UpHealth, Inc. (0001770141) (Filer)

      2/15/24 4:44:09 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form DEFM14A filed by UpHealth Inc.

      DEFM14A - UpHealth, Inc. (0001770141) (Filer)

      1/24/24 6:06:58 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology

    $UPH
    Financials

    Live finance-specific insights

    See more
    • UpHealth Announces Second Quarter 2023 Financial Results

      Second Quarter Revenues Were $37.8 million and Gross Margin Expanded to 53% Year-to-Date Net Loss Attributable to UpHealth, Inc. Improved 9% to $27.2 million Year-to-Date Adjusted EBITDA Improved by $9.2 million to $11.8 million Closed Strategic Sale of Innovations Group, Inc. for $56.0 million Completed Repurchase of $10.3 Million of Convertible Debt Increasing Full Year 2023 Outlook DELRAY BEACH, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financi

      8/10/23 4:15:05 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces Timing of Second Quarter 2023 Earnings Release and Conference Call

      DELRAY BEACH, Fla., July 25, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (NYSE:UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its second quarter ended June 30, 2023, after market close on Thursday, August 10, 2023. A conference call to discuss the results will follow at 5:00 p.m. Eastern Time on the same day. Those wishing to participate via the webcast should access the call through UpHealth's Investor Relations website at https://investors.uphealthinc.com. Those wishing to participate via the telep

      7/25/23 8:30:00 AM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology
    • UpHealth Announces First Quarter 2023 Financial Results

      First Quarter Revenues Increased 17% to $42.1 millionFirst Quarter Gross Margin Expanded to 54% First Quarter Net Loss Attributable to UpHealth, Inc. Decreased 54% to $8.1 millionFirst Quarter Adjusted EBITDA Improved by $7.9 million to $6.6 million Announced Strategic Sale of Innovations Group, Inc. for $56.0 million DELRAY BEACH, Fla., May 11, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. ("UpHealth" or the "Company") (NYSE:UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced financial results for the first quarter ended March 31, 2023. UpHealth Chief Executive Officer Sam Meckey

      5/11/23 4:08:05 PM ET
      $UPH
      Retail: Computer Software & Peripheral Equipment
      Technology